Article
Potent and selective repression of <i>SCN9A</i> by engineered zinc finger repressors for the treatment of neuropathic pain
2024-09-11
Abstract excerpt
<h4>ABSTRACT</h4> Peripheral neuropathies are estimated to affect several million patients in the US with no long-lasting therapy currently available. In humans, the Nav1.7 sodium channel, encoded by the SCN9A gene, is involved in a spectrum of inherited neuropathies, and has emerged as a promising target for analgesic drug development. The development of a selective Nav1.7 inhibitor has been challenging, in par...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 735d280e-8d45-54ba-8c5c-fa625f6e2f8e
- DOI
- 10.1101/2024.09.06.609976
